Packaging concept. Final appearance may change.
Malibu Wellness
MoodWell
Launch price coming soon
Internal development concept — not available for sale.
MoodWell revision 2.0 records a saffron, aniracetam and L-theanine combination for review.
Presentation target: 60 capsules. The amounts below refer to a two-capsule concept unit, not a validated serving or a consumer dosing recommendation.
The Malibu collection is in development. Only products with confirmed availability can be added to the cart.
Our manufacturing commitment
USA made · cGMP manufacturing
Formula and research details
Internal development concept — not available for sale.
MoodWell revision 2.0 records a saffron, aniracetam and L-theanine combination for review.
Presentation target: 60 capsules. The amounts below refer to a two-capsule concept unit, not a validated serving or a consumer dosing recommendation.
Formula development targets
| Ingredient | Per capsule | Per 2-capsule concept unit |
|---|---|---|
| Standardized saffron stigma extract (Affron specification, subject to supplier confirmation) | 14 mg | 28 mg |
| Aniracetam | 100 mg | 200 mg |
| L-theanine | 100 mg | 200 mg |
Internal review hold: aniracetam requires resolution of the product’s regulatory pathway before retail development or sales claims. The FDA has addressed aniracetam products as unapproved drugs. The capsule count is not a validated 30-day supply.
The Malibu standard
Premium formulation, a refined daily experience, and a commitment to U.S. manufacturing and transparent product testing. We don’t formulate to be the cheapest. We formulate to be exceptional.
Research context
A saffron/Affron 28 mg trial studied that ingredient in a particular population. It does not establish the safety or efficacy of aniracetam or this three-ingredient blend.
No completed clinical trial of this finished Malibu formula is documented in the product portfolio.
Development status
Coming soon. Formula and packaging targets are in development and subject to final verification. This draft is not a final product label or directions for use. Pricing has not been set. Manufacturing records, finished-product testing and final claims must be completed before release.